Maiwei Biotech Announces Quarterly Results: Total Revenue for 2025 Reached 663 million yuan, a year-over-year increase of 231.62%. Net profit attributable to owners of the parent company was -970 million yuan, compared to -1.044 billion yuan in the same period last year. Net profit excluding non-recurring gains and losses attributable to owners of the parent was -999 million yuan, compared to -1.07 billion yuan in the same period last year.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Maiwei Biotech: Total revenue of 663 million yuan in 2025, a year-on-year increase of 231.62%
Maiwei Biotech Announces Quarterly Results: Total Revenue for 2025 Reached 663 million yuan, a year-over-year increase of 231.62%. Net profit attributable to owners of the parent company was -970 million yuan, compared to -1.044 billion yuan in the same period last year. Net profit excluding non-recurring gains and losses attributable to owners of the parent was -999 million yuan, compared to -1.07 billion yuan in the same period last year.